Nizatidine
Encyclopedia
Nizatidine is a histamine H2-receptor antagonist
that inhibits stomach acid
production, and commonly used in the treatment of peptic ulcer
disease (PUD) and gastroesophageal reflux disease (GERD). It was developed by Eli Lilly
and is marketed under the brand names Tazac and Axid.
in various countries including the United States. Nizatidine has been used experimentally to control weight gain associated with some antipsychotic medication.
, and was first marketed in 1987. It is considered to be equipotent with ranitidine
and differs by the substitution of a thiazole
-ring in place of the furan
-ring in ranitidine. In September 2000 Eli Lilly announced they would sell the sales and marketing rights for Axid to Reliant Pharmaceuticals
. Subsequently, Reliant developed the oral solution of Axid, marketing this in 2004, after gaining approval from the U.S. Food and Drug Administration (FDA). However, a year later they sold rights of the Axid Oral Solution (including the issued patent US6,930,119 protecting the product) to Braintree Laboratories.
Nizatidine proved to be the last new histamine H2-receptor antagonist introduced prior to the advent of proton pump inhibitor
s.Not available OTC as inhibits metabolism of Warfarin.
H2-receptor antagonist
The H2 receptor antagonists are a class of drugs used to block the action of histamine on parietal cells in the stomach, decreasing the production of acid by these cells. H2 antagonists are used in the treatment of dyspepsia, although they have been surpassed in popularity by the more effective ...
that inhibits stomach acid
Gastric acid
Gastric acid is a digestive fluid, formed in the stomach. It has a pH of 1 to 2 and is composed of hydrochloric acid , and large quantities of potassium chloride and sodium chloride...
production, and commonly used in the treatment of peptic ulcer
Peptic ulcer
A peptic ulcer, also known as PUD or peptic ulcer disease, is the most common ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful. It is defined as mucosal erosions equal to or greater than 0.5 cm...
disease (PUD) and gastroesophageal reflux disease (GERD). It was developed by Eli Lilly
Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States...
and is marketed under the brand names Tazac and Axid.
Clinical use
Certain preparations of nizatidine are now available over the counterOver-the-counter drug
Over-the-counter drugs are medicines that may be sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription...
in various countries including the United States. Nizatidine has been used experimentally to control weight gain associated with some antipsychotic medication.
History and development
Nizatidine was developed by Eli LillyEli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States...
, and was first marketed in 1987. It is considered to be equipotent with ranitidine
Ranitidine
Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease and gastroesophageal reflux disease . Ranitidine is also used alongside fexofenadine and other antihistamines for the treatment of skin conditions...
and differs by the substitution of a thiazole
Thiazole
Thiazole, or 1,3-thiazole, is a heterocyclic compound that contains both sulfur and nitrogen; the term 'thiazole' also refers to a large family of derivatives. Thiazole itself is a pale yellow liquid with a pyridine-like odor and the molecular formula C3H3NS...
-ring in place of the furan
Furan
Furan is a heterocyclic organic compound, consisting of a five-membered aromatic ring with four carbon atoms and one oxygen. The class of compounds containing such rings are also referred to as furans....
-ring in ranitidine. In September 2000 Eli Lilly announced they would sell the sales and marketing rights for Axid to Reliant Pharmaceuticals
Reliant Pharmaceuticals
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007.It was known for six major products, including InnoPran XL, a propranolol based beta blocker....
. Subsequently, Reliant developed the oral solution of Axid, marketing this in 2004, after gaining approval from the U.S. Food and Drug Administration (FDA). However, a year later they sold rights of the Axid Oral Solution (including the issued patent US6,930,119 protecting the product) to Braintree Laboratories.
Nizatidine proved to be the last new histamine H2-receptor antagonist introduced prior to the advent of proton pump inhibitor
Proton pump inhibitor
Proton-pump inhibitors are a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production. They are the most potent inhibitors of acid secretion available today. The group followed and has largely superseded another group of pharmaceuticals with similar...
s.Not available OTC as inhibits metabolism of Warfarin.
External links
- http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=2929
- Axid @ FDA
- Axid Oral Solution